APA 6th Edition

Sajko, T. & Hećimović, H. (2013). Why is Epilepsy Surgery Better Option in Pharmacoresistant Patients. Acta clinica Croatica, 52. (Supplement 1), 21-21. Retrieved from https://hrcak.srce.hr/107048

---

MLA 8th Edition

Sajko, Tomislav and Hrvoje Hećimović. "Why is Epilepsy Surgery Better Option in Pharmacoresistant Patients." Acta clinica Croatica, vol. 52., no. Supplement 1, 2013, pp. 21-21. https://hrcak.srce.hr/107048. Accessed 18 Nov. 2024.

---

Chicago 17th Edition

Sajko, Tomislav and Hrvoje Hećimović. "Why is Epilepsy Surgery Better Option in Pharmacoresistant Patients." Acta clinica Croatica 52., no. Supplement 1 (2013): 21-21. https://hrcak.srce.hr/107048

---

Harvard

Sajko, T., and Hećimović, H. (2013). 'Why is Epilepsy Surgery Better Option in Pharmacoresistant Patients', Acta clinica Croatica, 52.(Supplement 1), pp. 21-21. Available at: https://hrcak.srce.hr/107048 (Accessed 18 November 2024)

---

Vancouver

Sajko T, Hećimović H. Why is Epilepsy Surgery Better Option in Pharmacoresistant Patients. Acta clinica Croatica [Internet]. 2013 [cited 2024 November 18];52.(Supplement 1):21-21. Available from: https://hrcak.srce.hr/107048

---

IEEE

T. Sajko and H. Hećimović, "Why is Epilepsy Surgery Better Option in Pharmacoresistant Patients", Acta clinica Croatica, vol.52., no. Supplement 1, pp. 21-21, 2013. [Online]. Available: https://hrcak.srce.hr/107048. [Accessed: 18 November 2024]